The 20 Best Small Cell Lung Cancer (SCLC) Doctors Near Me

Thomas Stinchcombe is an Oncologist and a Hematologist Oncology provider practicing medicine in Durham, North Carolina. Dr. Stinchcombe is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery. Dr. Stinchcombe is board certified in American Board Of Internal Med, Medical Oncology. Dr. Stinchcombe is currently accepting new patients.

Hossein Borghaei is an Oncologist and a Radiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Borghaei is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Borghaei is board certified in American Board Of Internal Medicine - Medical Oncology.

Ravi Salgia is an Oncologist practicing medicine in Duarte, California. Dr. Salgia is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Gastrostomy.

John Heymach is an Oncologist practicing medicine in Cary, North Carolina. Dr. Heymach is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

Zhongxing Liao is a Radiation Oncologist practicing medicine in Cary, North Carolina. Dr. Liao is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, and Small Cell Lung Cancer (SCLC).

Martin Edelman is an Oncologist practicing medicine in Philadelphia, Pennsylvania. He has been practicing medicine for over 44 years. Dr. Edelman is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Edelman is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.

Heather Wakelee is an Oncologist practicing medicine in San Jose, California. Dr. Wakelee is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, Thymectomy, and Tissue Biopsy.

Christopher Azzoli is a primary care provider, practicing in Internal Medicine in Providence, Rhode Island. Dr. Azzoli is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).

Jianjun Zhang is an Oncologist practicing medicine in Cary, North Carolina. Dr. Zhang is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Metastatic Pleural Tumor, and Non-Small Cell Lung Cancer (NSCLC).

Fiona Blackhall practices practicing medicine in Manchester, United Kingdom. Ms. Blackhall is rated as an Elite expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine. Dr. Hann is currently accepting new patients.

Suresh Ramalingam is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Ramalingam is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Ramalingam is board certified in American Board Of Internal Medicine, 2003. Dr. Ramalingam is currently accepting new patients.

Martin Reck-Deppermann practices practicing medicine in Grosshansdorf, Germany. Reck-Deppermann is rated as an Elite expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). They are also highly rated in 11 other conditions, according to our data. Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Endoscopy.

Alberto Chiappori is an Oncologist practicing medicine in Tampa, Florida. Dr. Chiappori is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Chiappori is currently accepting new patients.

Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.

Saiama Waqar is an Oncologist practicing medicine in Saint Louis, Missouri. Dr. Waqar is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Waqar is currently accepting new patients.

Marina Garassino is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Garassino is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Thymectomy. Dr. Garassino is currently accepting new patients.

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology. Dr. Kalemkerian is currently accepting new patients.

Everett Vokes is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Vokes is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Lung Cancer, Gastrostomy, and Bladder Reconstruction. Dr. Vokes is board certified in Internal Medicine Medical Oncology and Practicing Since1986. Dr. Vokes is currently accepting new patients.

Makoto Nishio practices practicing medicine in Tokyo, Japan. Mr. Nishio is rated as an Elite expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Tissue Biopsy, and Laryngectomy.